Pancreatic cancer is notoriously hard to treat and often resists the most advanced immunotherapies. Northwestern Medicine ...

Pancreatic cancer is notoriously hard to treat and often resists the most advanced immunotherapies. Northwestern Medicine scientists have uncovered a novel explanation for that resistance: Pancreatic ...

Oncolytics Biotech® Establishes Gastrointestinal Tumor Scientific Advisory Board to Advance Pelareorep as a Platform Immunotherapy ...

In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of ...

By restructuring a common chemotherapy drug, scientists increased its potency by 20,000 times. In a significant step forward for cancer therapy, researchers at Northwestern University have redesigned ...

Hippocratic AI raises $126 million in Series C funding, reaching a $3.5 billion valuation to scale safe, generative AI ...

(Reuters) -Hippocratic AI raised $126 million in its latest funding round led by Avenir Growth, it said on Monday, valuing the healthcare company at $3.5 billion and underscoring venture capital's ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today reported financial results for the quarter ended September 30, 2025 ...

In this video, Leo I. Gordon, MD, FACP, discusses notable presentations from Lymphoma, Leukemia & Myeloma Congress.

In this video, Leo I. Gordon, MD, FACP, discusses highlights from his presentation on extranodal marginal zone lymphomas at the Lymphoma Leukemia & Myeloma Congress.